Menu

AstraZeneca PLC (AZN) Q3 2026 Earnings Call Transcript
📰

AstraZeneca PLC (AZN) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·about 11 hours ago
#5C7536OR
#seekingalpha#research#executive#call#vice
Reading 0:00
15s threshold

AstraZeneca PLC ( AZN ) Q3 2026 Earnings Call October 30, 2026 10:30 AM EDT

Company Participants

Joris Silon - Head of Investor Relations

Pascal Soriot - CEO & Executive Director

Aradhana Sarin - CFO & Executive Director

David Fredrickson - Executive Vice-President of Oncology Haematology Business Unit

Susan Galbraith - Executive Vice President of Oncology R&D

Ruud Dobber - Executive Vice-President of BioPharmaceuticals Business Unit

Sharon Barr - Executive Vice-President of BioPharmaceuticals R&D

Marc Dunoyer - CEO of Alexion & Chief Strategy Officer

Iskra Reic - Executive Vice President of International

Conference Call Participants

Mattias Häggblom - Nordea Markets, Research Division

Simon Baker - Rothschild & Co Redburn, Research Division

Sachin Jain - BofA Securities, Research Division

Steve Scala - TD Cowen, Research Division

Richard Vosser - JPMorgan Chase & Co, Research Division

Graham Glyn Parry - Citigroup Inc., Research Division

Rajan Sharma - Goldman Sachs Group, Inc., Research…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.